SIG | Engineering and Neurostimulation: Neurostimulation by Design - Engineering for Usability, Access, and Impact

Friday, December 4, 2026 at 3:30 PM to 5:00 PM · 1 hr. 30 min. (America/Denver)
Special Interest Group

Information

Despite major engineering advances, the real-world usability of FDA-approved neurostimulation devices (RNS/DBS) remains limited for both clinicians and patients. Complex data workflows, time-intensive programming, and dependence on frequent in-person visits restrict access and confine effective use to a small number of highly specialized providers. This SIG examines how human-centered engineering, remote care technologies, automation, and biomarker-guided adaptive systems can close usability and access gaps. The session features three high-impact debates in which leaders in neurostimulation go head-to-head to define the next generation of scalable, personalized epilepsy neuromodulation.
Learning Objective 1
Identify key clinician usability challenges in current neurostimulation systems and explain how engineering innovations can reduce provider burden and enable broader clinical use
Learning Objective 2
Evaluate strategies to support patients and expand access to neurostimulation while maintaining safety, efficacy, and equity
Learning Objective 3
Explore emerging biomarkers for next-generation adaptive stimulation and explain how they may improve seizure detection, prediction, and real-time therapy
Target Audience
CliniciansFellows/TraineesAdvanced Practice Providers (APPs)NursesScientists/ResearchersTechnicians
Career Stage
Early Career (typically 0-5 years from completion of training)Mid-Career (typically 6-15 years from completion of trainingSenior (typically >15 years from completion of training)
Demographics
ClinicalYoung ProfessionalsResearchFirst-time Attendee
Session Content Includes
and Inclusion (DEI)DiversityEquityPatient Perspective
Session ID
ENGINEERINGSIG26
Presentation Id
3452233
Event ID
24056
Session Type
Session